数据链接：
官方服务：
资源简介：
Current malaria vaccine clinical trial pipeline.
应用场景：
创建时间：
2016-10-13
相关数据集
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or With-out Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
The study intends to establish proof of concept for a fractional dose schedule under conditions of natural exposure in children 5-17 months old at first vaccination. The study also aims to establish t
DataCite Commons2026-02-18 更新50
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children
KSPZV1 Part 2 is a single center, randomized, double-blind, placebo-controlled trial enrolling 336 malaria-exposed Kenyan children ages 5 to 12 months at the time of first vaccination. Subjects were r
Immunology Database and Analysis Portal2025-10-30 更新20
Transcription profiling of PfSPZ Malaria Vaccine trial subjects in a malaria endemic region
The Sanaria® PfSPZ Vaccine can confer sterilizing protection against liver stage infection by Plasmodium falciparum (Pf) in malaria naïve individuals. The vaccine consists of aseptically purified ir
NIAID Data Ecosystem20
Dataset from Safety and Immunogenicity Study of GSK Biologicals' Plasmodium Falciparum Malaria Vaccine 257049 Administered to HIV Infected Infants and Children
The purpose of this study is to assess the safety and immunogenicity of the candidate malaria vaccine in HIV-infected infants and children
NIAID Data Ecosystem40
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
Malaria transmission is in decline in some parts of Africa, partly due to the scaling up of control measures. If the goal of elimination is to be achieved, additional control measures including an eff
Figshare2016-12-16 更新20
